Google DeepMind Restructures AlphaFold Team for Broader AI Discovery
Google DeepMind has dismantled its Nobel-winning AlphaFold team as part of a strategic shift, moving towards a wider effort to build AI systems for general scientific discovery.
Results for "AlphaFold"
7 stories found
Worldbloombergcnbcaftonbladet+14berlingskele-figarovgel-mundopublicoBusiness Insiderobservadorhindustan-times+6 more2mo ago17 sources
Nobel Laureate François Englert, Pioneer of Higgs Boson Theory, Dies at 93
Belgian physicist François Englert, who shared the Nobel Prize for his work on the theory of the Higgs boson, has died at the age of 93. Separately, Nobel laureate John Jumper announced his departure from Google DeepMind to join Anthropic.
Icelandic Chemist Páll Þórðarson Contributes to AI-Powered Cancer Treatment for Dog Rosie
Icelandic chemist Páll Þórðarson has gained attention in Australia for his involvement in a project that successfully cured a dog named Rosie of cancer using artificial intelligence, further highlighting the application of AI in personalized medicine.
Flaw in Google DeepMind's AlphaFold AI Corrected by Austrian Team
A team from Austria has successfully corrected a limitation in Google DeepMind's Nobel Prize-winning AlphaFold AI model, which previously underestimated protein flexibility due to restricted training data.
Nobel Laureate AI Researcher John Jumper Departs Google DeepMind for Anthropic
John Jumper, a Nobel laureate recognized for his work on AI protein structure prediction with AlphaFold, is leaving Google DeepMind to join Anthropic. This significant departure follows closely after Noam Shazeer also left the company.
Google DeepMind Scientist John Jumper Joins Anthropic
John Jumper, a leading scientist known as the 'father of AlphaFold' at Google DeepMind, is leaving the company to join Anthropic. His departure marks a significant move in the artificial intelligence research community.
Alphafold 3 Digital Assistant Aids Research for Cancer, Alzheimer's, Parkinson's Treatments
A new global-scale digital assistant for Alphafold 3 has been introduced, designed to help researchers accelerate the development of treatments for diseases like cancer, Alzheimer's, and Parkinson's.